Micro-costing improves the specificity

of the cost estima

Micro-costing improves the specificity

of the cost estimate, but it is often impractical to precisely JQ-EZ-05 measure resources at this level and the price weights for these micro-units may not be available. Gross-costing may be more practical, and price weights are often easier to find and are more reliable, but important resource differences between treatment groups may be lost in the bundling of resources. Price weights can either tie nationally determined or centre specific, but the appropriate price weight will depend oil perspective, convenience, completeness and accuracy. Identifying the resource types and the appropriate price weights for these resources are the essential elements to an accurate valuation of costs.

Once medical services are valued, the resulting individual patient cost estimates must be analysed. The difference in the mean cost between treatment groups is the important summary statistic for cost-effectiveness analysis from both the budgetary and the social perspectives. The statistical challenges with cost data typically stein from PF-00299804 inhibitor its skewed distribution and the resulting possibility that the sample mean may be inefficient and possibly inappropriate for

statistical inference. Multivariable analysis of cost is useful, even if the data come from an RCT, but the same distributional problems that affect univariate tests of cost also affect use of cost as a dependent variable in a multivariable regression analysis. The generalized linear model (GLM) overcomes many of the problems of more common cost models, but caution must be used when applying this model because it is prone to mis-specification and precision losses in data

with a heavy-tailed log error term.

Attention to the appropriate cost valuation and analysis techniques reviewed here will help bring the same level of rigor and attention to the methodological issues in cost valuation as is currently applied to clinical evidence within RCTs.”
“Objectives: This study aimed to investigate the role of tumor necrosis factor (TNF)-alpha and the neuronal buy Bafilomycin A1 nitric oxide synthase enzyme in dysregulation of indoleamine 2,3-dioxygenase (IDO) enzyme, and hence serotonin availability in chronic mild stress (CMS), an animal model of depression.

Methods: Rats were divided into five groups: two control and CMS-exposed for 6 weeks, and another three groups exposed to CMS and administered pentoxifylline 50 mg/kg/day intraperitoneally, 7-nitroindazole 40 mg/kg/day subcutaneously, or imipramine 20 mg/kg/day intraperitoneally for the previous 3 CMS weeks. Rats were assessed for neurochemical and immunohistochemical abnormalities.

Results: Pentoxifylline-, 7-nitroindazole-, and imipramine-treated rats showed amelioration of CMS-induced behavioral deficits that was accompanied by significant reduction in kynurenine/serotonin molar ratio and nitrates/nitrites in frontal cortex and hippocampus.

Comments are closed.